Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.5 USD | 0.00% |
|
+6.66% | -13.20% |
Jul. 01 | IBEX Limited(NasdaqGM:IBEX) added to Russell Small Cap Comp Value Index | CI |
Jul. 01 | IBEX Limited(NasdaqGM:IBEX) dropped from Russell Microcap Growth Index | CI |
Valuation
Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 358.9 | 310.4 | 387.4 | 284 | - | - |
Enterprise Value (EV) 1 | 413.6 | 366.3 | 387.4 | 284 | 284 | 284 |
P/E ratio | 130 x | 13.7 x | 12.7 x | - | - | - |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.81 x | 0.63 x | 0.74 x | 0.56 x | 0.54 x | 0.5 x |
EV / Revenue | 0.81 x | 0.63 x | 0.74 x | 0.56 x | 0.54 x | 0.5 x |
EV / EBITDA | 5.42 x | 4.64 x | 5.82 x | 4.43 x | 4.11 x | 3.67 x |
EV / FCF | 70,740,456 x | 12,820,828 x | 16,912,080 x | - | - | - |
FCF Yield | 0% | 0% | 0% | - | - | - |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 18,388 | 18,399 | 18,248 | 17,214 | - | - |
Reference price 2 | 19.52 | 16.87 | 21.23 | 16.50 | 16.50 | 16.50 |
Announcement Date | 9/14/21 | 9/22/22 | 9/13/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | 405.1 | 443.7 | 493.6 | 523.1 | 506.3 | 521.7 | 565.4 |
EBITDA 1 | 54.15 | 66.24 | 66.84 | 66.59 | 64.1 | 69.19 | 77.39 |
EBIT 1 | 19.51 | 13.8 | 29.8 | 40.48 | 37.2 | 45.94 | 52.73 |
Operating Margin | 4.82% | 3.11% | 6.04% | 7.74% | 7.35% | 8.81% | 9.33% |
Earnings before Tax (EBT) 1 | 10.08 | 4.765 | 21 | 40.33 | 38.9 | 45.3 | 53.4 |
Net income 1 | 7.77 | 2.847 | 22.99 | 31.58 | 32.7 | 36.2 | 42.7 |
Net margin | 1.92% | 0.64% | 4.66% | 6.04% | 6.46% | 6.94% | 7.55% |
EPS | 0.4159 | 0.1500 | 1.230 | 1.670 | - | - | - |
Free Cash Flow | 25.66 | 5.074 | 24.21 | 22.91 | - | - | - |
FCF margin | 6.33% | 1.14% | 4.91% | 4.38% | - | - | - |
FCF Conversion (EBITDA) | 47.38% | 7.66% | 36.22% | 34.4% | - | - | - |
FCF Conversion (Net income) | 330.18% | 178.22% | 105.31% | 72.53% | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - | - |
Announcement Date | 9/24/20 | 9/14/21 | 9/22/22 | 9/13/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 132.2 | 129.1 | 123.7 | 127.9 | 139.4 | 131.6 | 124.4 | 124.6 | 132.6 | 126.8 | 122.3 | 124 | 134.3 | 130.3 | 128.1 |
EBITDA 1 | 17.84 | 18.79 | 18.74 | 18.24 | 25.06 | 24.36 | 15.44 | 13.71 | 14.32 | 19.2 | 16.9 | 16 | 14.8 | 19.3 | 19.1 |
EBIT 1 | 12.12 | 5.887 | 6.081 | 7.265 | 6.015 | 15.38 | 8.306 | 8.331 | 6.947 | 11.28 | 10.7 | 9.7 | 8.4 | 12.8 | 12.4 |
Operating Margin | 9.17% | 4.56% | 4.92% | 5.68% | 4.32% | 11.69% | 6.68% | 6.69% | 5.24% | 8.9% | 8.75% | 7.82% | 6.26% | 9.83% | 9.68% |
Earnings before Tax (EBT) 1 | 9.805 | 3.712 | 3.879 | 5.396 | 3.93 | 13.61 | 8.316 | 8.813 | 7.348 | 11.59 | 11.2 | 10.2 | 8.9 | 13.3 | 12.9 |
Net income 1 | 8.465 | 6.598 | 4.913 | 4.306 | 1.865 | 11.7 | 4.51 | 7.425 | 6.075 | 10.31 | 8.9 | 8.2 | 7.1 | 10.6 | 10.3 |
Net margin | 6.4% | 5.11% | 3.97% | 3.37% | 1.34% | 8.89% | 3.62% | 5.96% | 4.58% | 8.13% | 7.28% | 6.61% | 5.29% | 8.14% | 8.04% |
EPS | 0.4500 | 0.3500 | 0.2600 | 0.2300 | 0.1000 | 0.6100 | 0.2400 | 0.3900 | 0.3400 | - | - | - | - | - | - |
Dividend per Share 2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 2/16/22 | 5/18/22 | 9/22/22 | 11/15/22 | 2/15/23 | 5/17/23 | 9/13/23 | 11/9/23 | 2/8/24 | 5/9/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: June | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | 84.1 | 54.7 | 55.9 | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.553 x | 0.8253 x | 0.8365 x | - | - | - | - |
Free Cash Flow | 25.7 | 5.07 | 24.2 | 22.9 | - | - | - |
ROE (net income / shareholders' equity) | 62.7% | 3.53% | 25.4% | 24% | 21.6% | 19.4% | 16.7% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | 16.9 | 20.8 | 25.9 | 19 | - | - | - |
Capex / Sales | 4.18% | 4.69% | 5.25% | 3.62% | - | - | - |
Announcement Date | 9/24/20 | 9/14/21 | 9/22/22 | 9/13/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-13.20% | 284M | |
-6.29% | 248B | |
-16.67% | 61.02B | |
+2.42% | 59.77B | |
+4.12% | 54.62B | |
+5.29% | 42.75B | |
+6.48% | 38.71B | |
-9.24% | 28.75B | |
+112.95% | 27.92B | |
+4.42% | 21.88B |
- Stock Market
- Equities
- IBEX Stock
- Financials IBEX Limited